(PhysOrg.com) -- Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. One approach showing promise in overcoming multidrug resistance in tumors is to combine two different anticancer ...
Bio & Medicine
Nov 4, 2009
0
0
(PhysOrg.com) -- Scientists from the U.S. Department of Energy’s (DOE) Argonne National Laboratory and the University of Chicago Medical Center’s Brain Tumor Center have developed a way to target brain cancer cells using ...
Bio & Medicine
Sep 24, 2009
6
1
Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types ...
Bio & Medicine
Jul 22, 2009
0
0
Dr. Esther Chang describes the most recent developments in human trials of the first systemic, non-viral, tumor-targeted, nanoparticle method designed to restore normal gene function to tumor cells while completely bypassing ...
Bio & Medicine
Apr 20, 2009
0
0
A study published in a special issue of Photochemistry and Photobiology examines the emerging practice of drug delivery systems which use the application of light to activate medications in the body.
Biochemistry
Mar 30, 2009
0
0
Breast cancer patients face many horrors, including those that arise when fighting the cancer itself. Medications given during chemotherapy can have wicked side effects, including vomiting, dizziness, anemia and hair loss. ...
Bio & Medicine
Mar 10, 2009
1
0
(PhysOrg.com) -- A team of Michigan Technological University researchers led by Associate Professor of Chemistry Haiying Liu has discovered how to make a strain of E. coli glow under fluorescent light. The technique could ...
Biochemistry
Mar 5, 2009
0
0
Fruit flies and humans share most of their genes, including 70 percent of all known human disease genes. Taking advantage of this remarkable evolutionary conservation, researchers at the Salk Institute for Biological Studies ...
Feb 13, 2009
0
0
